Technology C2N Diagnostics Announces Follow-on Investment from GHR Foundation as It Builds on Success in Novel… Business Wire Feb 17, 2023 C2N Diagnostics, LLC, a leader in advanced brain health diagnostics, announced it has received a $15 million program-related investment from GHR…
Diagnosis C2N Diagnostics Introduces P-tau Multi-Analyte Assay for Research Use Only to Advance Alzheimer’s… AIT News Desk May 26, 2022 P-tau Multi-Analyte Assay (MAA) Uses High-Resolution Mass Spectrometry to Precisely Quantitate Four Analytes Related to Phosphorylated and…